FindMyKOL
Clinical trialNCT01844921CompletedObservational

High Resolution Optical Imaging of the Esophagus Using the Nvision Volumetric Laser Endomicroscopy (VLE™) Imaging System

NCT01844921 is an observational study sponsored by NinePoint Medical. As of 21 Nov 2026, it is completed. It studies Undergoing Esophagogastroduodenoscopy (EGD). The registry lists an enrollment of 10 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2013 and a primary completion date of 31 May 2013.

SponsorNinePoint MedicalEnrollment10Undergoing Esophagogastroduodenoscopy (EGD)
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01844921
FieldValue
Registry IDNCT01844921
StatusCompleted
Study typeObservational study
Lead sponsorNinePoint Medical
Enrollment10
Registered sites1
Countries1
ConditionsUndergoing Esophagogastroduodenoscopy (EGD)
Start30 Apr 2013
Primary completion31 May 2013
Study completion31 May 2013
Last update posted17 May 2013

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a single center, single arm, open label observational trial of patients undergoing EGD. The primary objective of this clinical trial is to evaluate the ability of physicians to position the NvisionVLE catheter to acquire an image of an area of the esophagus to identify and discriminate abnormal areas of tissue from normal.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • Columbia University Medical Center

    New York

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01844921

Each answer restates registry values shown on this page.

What is NCT01844921?

NCT01844921 is an observational study sponsored by NinePoint Medical. It studies Undergoing Esophagogastroduodenoscopy (EGD).

Who leads NCT01844921?

The registry names John Poneros, MD (principal investigator, Columbia University) as the overall official.

Where does NCT01844921 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01844921 end?

The registry lists a primary completion date of 31 May 2013 and a study completion date of 31 May 2013. The sponsor last updated the record on 17 May 2013.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.